PCD-related genes promote metastasis and poor survival through VEGF/HIF-1/MAPK signaling and Th1/Th2 imbalance, while new tumor events (metastasis/secondary cancers) associate with TP53/CDH1 mutations and genomic instability. The gene discussed is TP53; the disease is cancer.